Kurzfassung

An international, multicentre, randomised, open-label, parallel group study to evaluate
the efficacy and safety of two different dose regimens of immunotherapy with
allogeneic dendritic cell vaccination with DCP-001 compared to standard care in
patients with acute myeloid leukaemia